These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16251126

  • 1. Platelet-activating factor in human normal tears.
    Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H.
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
    Okumura N, Fukushima A, Igarashi A, Sumi T, Yamagishi T, Ueno H.
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
    [Abstract] [Full Text] [Related]

  • 3. Renal allograft platelet activating factor synthesis during acute cellular rejection.
    Mangino MJ, Anderson CB, Murphy MK, Turk J.
    J Lipid Mediat; 1991 Oct; 4(1):69-81. PubMed ID: 1893087
    [Abstract] [Full Text] [Related]

  • 4. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
    Kato M, Mano H, Ota A, Konomi K, Nakata K.
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
    [Abstract] [Full Text] [Related]

  • 5. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C, Laurent L, Junier MP, Dray F.
    J Lipid Mediat; 1991 Feb; 3(3):249-66. PubMed ID: 1773028
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory cytokines in normal human tears.
    Nakamura Y, Sotozono C, Kinoshita S.
    Curr Eye Res; 1998 Jun; 17(6):673-6. PubMed ID: 9663859
    [Abstract] [Full Text] [Related]

  • 7. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine).
    Harrison KA, Clay KL, Murphy RC.
    J Mass Spectrom; 1999 Apr; 34(4):330-5. PubMed ID: 10226361
    [Abstract] [Full Text] [Related]

  • 8. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
    Thyssen E, Turk J, Bohrer A, Stenson WF.
    Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
    [Abstract] [Full Text] [Related]

  • 9. Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
    Masugi F, Sakaguchi K, Saeki S, Imaoka M, Ogihara T.
    J Lipid Mediat; 1989 Mar; 1(6):341-8. PubMed ID: 2519902
    [Abstract] [Full Text] [Related]

  • 10. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS, Pickett WC.
    J Immunol; 1987 Mar 01; 138(5):1559-63. PubMed ID: 3100641
    [Abstract] [Full Text] [Related]

  • 11. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
    Christman BW, Gay JC, Christman JW, Prakash C, Blair IA.
    Biol Mass Spectrom; 1991 Sep 01; 20(9):545-52. PubMed ID: 1782204
    [Abstract] [Full Text] [Related]

  • 12. Quantitative determination of major platelet activating factors from human plasma.
    Kim SJ, Back SH, Koh JM, Yoo HJ.
    Anal Bioanal Chem; 2014 May 01; 406(13):3111-8. PubMed ID: 24682147
    [Abstract] [Full Text] [Related]

  • 13. [Platelet-activating factor in Japanese cedar pollinosis].
    Nakamura T, Ishihara K, Kuriyama M, Miyamoto T, Matsumura Y.
    Arerugi; 1990 Jun 01; 39(6):553-6. PubMed ID: 2222198
    [Abstract] [Full Text] [Related]

  • 14. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
    Whitehead SN, Hou W, Ethier M, Smith JC, Bourgeois A, Denis R, Bennett SA, Figeys D.
    Anal Chem; 2007 Nov 15; 79(22):8539-48. PubMed ID: 17949058
    [Abstract] [Full Text] [Related]

  • 15. Potential angiogenic role of platelet-activating factor in human breast cancer.
    Montrucchio G, Sapino A, Bussolati B, Ghisolfi G, Rizea-Savu S, Silvestro L, Lupia E, Camussi G.
    Am J Pathol; 1998 Nov 15; 153(5):1589-96. PubMed ID: 9811351
    [Abstract] [Full Text] [Related]

  • 16. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L, Roche A, Dubray C, Arnoux C, Benveniste J.
    Inflamm Res; 1996 May 15; 45(5):234-8. PubMed ID: 8737746
    [Abstract] [Full Text] [Related]

  • 17. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics.
    Detopoulou P, Nomikos T, Fragopoulou E, Stamatakis G, Panagiotakos DB, Antonopoulou S.
    Prostaglandins Other Lipid Mediat; 2012 Jan 15; 97(1-2):43-9. PubMed ID: 22079887
    [Abstract] [Full Text] [Related]

  • 18. L-carnitine and short chain ester in tears from patients with dry eye.
    Pescosolido N, Imperatrice B, Koverech A, Messano M.
    Optom Vis Sci; 2009 Feb 15; 86(2):E132-8. PubMed ID: 19156017
    [Abstract] [Full Text] [Related]

  • 19. Structural heterogeneity of platelet-activating factor produced by murine preimplantation embryos.
    Ammit AJ, Wells XE, O'Neill C.
    Hum Reprod; 1992 Jul 15; 7(6):865-70. PubMed ID: 1500487
    [Abstract] [Full Text] [Related]

  • 20. Binding of platelet-activating factor to oviductal membranes during early pregnancy in the rabbit.
    Yang YQ, Kudolo GB, Harper MJ.
    J Lipid Mediat; 1992 Feb 15; 5(1):77-96. PubMed ID: 1391740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.